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Abstract
Hyaluronic acid (HA) is found in high concentrations in cartilage and synovial fluid, and is an important component 
of the extracellular matrixes – exerting joint lubrication and buffering actions thanks to its viscoelastic properties.
The present study examines the scientific evidence found in the current literature on the usefulness of the intraar-
ticular injection of HA in patients with temporomandibular dysfunction.
A literature search was made up until May 2008 in the following databases: PubMed / MEDLINE. Of the articles 
found in the literature, the present review included 18 relevant studies on the application of HA in the temporo-
mandibular joint (TMJ). The quality, level of evidence and strength of recommendation of the articles was evalu-
ated based on the “Strength of Recommendation Taxonomy” criteria.
It is concluded that type A level of recommendation exists in favor of the intraarticular injection of HA in dysfunc-
tion of the TMJ. However, further studies are needed to establish the true therapeutic effects and to identify the 
best dosing regimen.
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Introduction
Hyaluronic acid (HA) is a linear, hydrophilic, polyani-
onic high molecular weight polysaccharide exclusively 
composed of repeated disaccharide units of glucuronic 
acid and N-acetylglucosamine. HA is a natural compo-
nent of joint synovial fluid, and is also found in the ex-
tracellular matrix of connective tissue (1,2). The authors 
that make use of HA consider that the intraarticular in-
jection of HA in patients with temporomandibular joint 
dysfunction (TMJD) improves function and lessens 
pain. The excellent mechanical and metabolic proper-
ties of the molecule define it as an ideal treatment for 
inflammatory problems of the temporomandibular joint 
(TMJ) (3,4).
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Authors Year
Level of 
evidence
Sample size Injection Dose-times Results
Kopp et 
al.(10) 1991 1
14
14
13
HA
CO
SA
0.7 ml x 2 every 2 weeks CO>HA
Kopp et al.(5) 1987 1 1512
HA
CO 0.5 ml x 2 every 2 weeks HA>CO
Sato et al.(4, 
14, 17) 
2001
2001
1997
2
60 + 76
59 + 62
26 + 50
Anesthesia, 
drainage+HA
Control
1 ml every week for 5 
weeks HA>control
Hepguler et 
al.(1) 2002 1
19
19
HA
SA
0.5 ml every week, for 6 
months HA>SA
Alpaslan et 
al.(2) 2001 1 31 Anesthesia, SA ± HA
200-300 ml ± 1 ml, a 
single time
Arthrocentesis with 
HA>without HA
McCain et 
al.(11) 1989 1
33
22
Hylan fluid
Control 3 ml + abundant SA Hylan fluid ≥HA
Møystad et 
al.(13) 2008 1
20
20
HA
CO 2 injections 2 weeks apart HA = CO
Bjørnland et 
al.(12) 2007 1
20
20
Anesthesia and HA
Anesthesia and CO
2 injections of 0.7-1 ml 14 
days apart HA > CO
Table 1. The most relevant studies comparing different treatments (intraarticular injection), mainly between hyaluronic acid (HA), glucocorticoids 
(CO) and saline solution (SA).
The mechanical action of HA is based on joint lubri-
cation and consequently lessened joint wear secondary 
to adhesions, with a reduction in friction within the 
intraarticular space. HA also reduces the levels of in-
flammatory mediators, thus contributing to afford relief 
from joint pain (1,2, 4-7). Its metabolic activity in turn 
involves the facilitation of nutrition in avascular zones 
of the joint disc and cartilage. HA acts in the combi-
nation of glycosaminoglycans to form proteoglycan, 
which under pathological conditions disintegrates and 
disperses within the synovial cavity (4-8). Despite the 
fact that its half-life is about 13 hours, the intraarticu-
lar application of HA offers persistent beneficial effects 
(2,3,7). 
The excellent lubricating properties of the molecule may 
offer a conservative, safe and effective alternative to the 
existing treatments which offer less satisfactory results 
in application to certain joint dysfunctions (1,2, 4-7). 
The present study was therefore designed to determine 
whether the level of scientific evidence found in the lit-
erature justifies the recommendation of intraarticular 
HA injection in the clinical management of TMJD.
Material and Methods
A MEDLINE search was made covering the period be-
tween 1966 and 2008, applying synonyms and Medical 
Subject Headings (MeSH) first for temporomandibular 
joint dysfunction (TMJD) and then for hyaluronic acid 
(HA), with the purpose of generating a principal series 
of articles. Posteriorly, the identified literature was lim-
ited to human studies and articles published in English. 
Both search strategies were in turn combined by means 
of an “AND” boolean operator, thus crossing the arti-
cles on TMJD and HA.
Two of the authors analyzed the identified articles to de-
termine whether they were pertinent to the study, with 
exclusion of those papers considered to be irrelevant. 
Then, separately and based on the SORT (Strength of 
Recommendation Taxonomy) criteria, the two authors 
stratified the studies according to their level of scientific 
evidence (9). This was followed by correlation of the re-
sults, and any observed discrepancies were subjected to 
discussion. If no consensus could be reached regarding 
the level of scientific evidence of a given article, another 
author was included in the discussion. Posteriorly, and 
according to the established level of evidence of the arti-
cles, a level of recommendation (in favor or against) was 
issued on the use of HA for the treatment of TMJD.
Results
The MEDLINE search yielded 10,000 articles for 
TMJD and 5956 for HA. As mentioned above, both 
search strategies were crossed to yield a pool of 28 arti-
cles. The article abstracts were then examined to estab-
lish whether the publications were relevant to the study 
subject. A total of 18 relevant articles were identified. 
These were critically reviewed and classified according 
to their level of scientific evidence. Posteriorly, and ac-
cording to the results obtained by these articles, a level 
of recommendation (in favor or against) was established 
regarding the intraarticular injection of HA (9).
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The analysis yielded 9 articles with level of evidence 1 
(1-3, 5,8, 10-13), and 7 with level of evidence 2 (4,6,7, 
14-17). The 9 publications classified as being of high 
quality were randomized double-blind studies with ad-
equate sample sizes, parallel groups, statistical analysis 
and adequate follow-up. On the other hand, the 7 publi-
cations classified as presenting limited quality evidence 
were non-randomized studies with an adequate sample 
size, parallel groups, statistical analysis and adequate 
follow-up. Based on these publications we established 
strength of recommendation A in favor of the use of HA 
in the treatment TMJD: reducible disc displacement 
(RDD), non-reducible disc displacement (NRDD), and 
other degenerative joint diseases.
The characteristics of the reviewed studies allowed us 
to include them in groups according to the treatments 
prescribed. Three types of comparisons were identified: 
HA versus placebo, HA versus glucocorticoids (CO), 
and arthroscopy or arthrocentesis combined with HA 
versus arthroscopy or arthrocentesis with placebo (Ta-
ble 1).
Discussion
Hyaluronic acid (HA) is the principal natural compo-
nent of synovial fluid. Although it has great importance 
in joint lubrication, the mechanism by which HA affords 
improvement in joint disease is not entirely clear. In the 
relevant studies found in the literature, HA was com-
pared with placebo, glucocorticoids (CO) and combined 
with other surgical treatments (arthroscopy or arthro-
centesis). The Helkimo clinical dysfunction index and 
subjective symptoms of mandibular function, pain and 
joint sounds as measured by multiple response ques-
tionnaires and a visual analog scale (VAS) provided an 
indication as to the positive or negative recommenda-
tion of treatment with HA.
Comparing hyaluronic acid with placebo, Bertolami et 
al. (3) designed a multicenter study with a duration of 
6 months in which they examined the effects of the in-
traarticular injection of HA in 80 patients (experimen-
tal group): 35 with reducible disc displacement (RDD), 
8 with non-reducible disc displacement (NRDD), and 
37 with degenerative joint disease (DJD). The placebo 
group included 41 patients: 15 with RDD, 6 with NRDD 
and 20 with DJD. For measuring joint dysfunction and 
the course after treatment, the authors used two indexes 
proposed by Helkimo: the anamnesis index for describ-
ing patient perception of the clinical problem and treat-
ment efficacy, and the clinical dysfunction index for de-
termining the functional condition of the joint. The re-
sults showed significant improvement of these indexes 
in the RDD patients treated with HA versus the placebo 
group. In patients with NRDD and DJD, improvement 
was seen in both groups, though without statistically 
significant differences between them.
Patients with very advanced-stage DJD or with ankylo-
sis of the TMJ generally caused by trauma may require 
surgery to solve the problem (18).
Hepguler et al. (1) examined the efficacy of HA in 38 
patients with RDD. These authors used a VAS to assess 
pain and the intensity of joint sounds, together with a 
modification of the Helkimo clinical dysfunction index. 
The evaluation was made before the first application, 
after one month and again after 6 months. The authors 
recorded significant improvement of all the symptoms 
in 17 (89.5%) of the 19 RDD patients treated with HA, 
while the placebo group showed no significant varia-
tions - with the exception of pain, which improved after 
one and 6 months. In these two well designed, rand-
omized and double blind high-quality studies, HA was 
applied to a total of 54 patients with RDD, with clinical 
improvement in relation to joint sounds and mandibular 
deviation, as well as partial remission of the symptoms 
assessed by the Helkimo index. The results of these au-
thors (1, 3) present strength of recommendation type A 
favorable to the intraarticular application of HA in pa-
tients with RDD.
In relation to NRDD, Sato et al. (4,7,14,17) examined 
maximum oral opening, laterality, TMJ pain and mas-
ticatory muscle discomfort in patients with this type of 
disc displacement. The authors showed the intraarticu-
lar injection of HA to be significantly more effective in 
securing clinical symptoms remission after 6, 12 and 24 
months than simple conservative observation of NRDD. 
Using electromyography (EMG) and mandibular kine-
siography (MKG), Sato et al. (15,16) in 20 patients with 
NRDD likewise found the intraarticular injection of HA 
to allow near normalization of the duration of contrac-
tion, masseter and temporal muscle function, and chew-
ing movements and efficacy. It can be seen that although 
the injection of HA does not improve disc position or 
deformation, the symptoms subside and oral opening 
can increase even in those cases where disc deforma-
tion and displacement persist. Of these publications 
by Sato et al. (15,16), we highlight the observation that 
the intraarticular application of HA improves function 
and reduces pain in patients with NRDD. The differ-
ent studies carried out by Sato et al. involve a correct 
clinical follow-up period of between 6 and 24 months, 
and have an adequate sample size. Nevertheless, their 
quality is limited, since they are not randomized. As a 
result, in NRDD, the strength of recommendation for 
the application of HA, while still positive, is of type B 
in these studies (4,7, 14-17).
The patients with rheumatoid arthritis studied by Kopp 
et al. (10) obtained improvement of the symptoms such 
as TMJ pain and pain in different facial zones, diffi-
culty in opening the mouth, joint sounds and pain in 
other joints, as measured by a multiple response ques-
tionnaire, a visual analog scale (VAS) and the Helkimo 
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clinical dysfunction index. The end symptoms, com-
pared with the situation before treatment, had improved 
in 10 of the 14 patients treated with HA, and in 9 of the 
13 patients of the placebo group. The mean symptoms 
reduction on the VAS was 11 mm in the HA group and 8 
mm in the placebo group, while the clinical dysfunction 
index showed a mean 5-point reduction in both groups. 
This is the only high quality study in which HA is com-
pared with placebo in patients with rheumatoid arthritis 
(10). The results yielded type A recommendation that is 
neither in favor nor against the intraarticular injection 
of HA in the treatment of this type of temporomandibu-
lar disorder.
Comparison has also been made of the effect of HA 
versus glucocorticoids (CO). Kopp et al. (10) used the 
intraarticular injection of HA or CO in patients with 
TMJD refractory to conservative management. The 
symptoms were evaluated by the clinical dysfunction 
index, and by a 10-item questionnaire including the as-
sessment of TMJ pain and pain in different zones of the 
face, difficulty opening the mouth, joint sounds, the du-
ration of symptoms, and pain in other joints. The authors 
recorded improvement in both groups, with symptoms 
remission in 13 of the 18 patients treated with HA and 
in 9 of the 15 patients treated with CO after four weeks 
of follow-up. In another similar study by the same au-
thors (5) and involving two years of follow-up, similar 
improvement was recorded for both types of treatment 
(HA and CO) according to the clinical dysfunction in-
dex. Nevertheless, Bjørnland et al. (12) considered that 
HA injections are more effective than CO in combat-
ing the intensity of pain, and that patients only present-
ing TMJ pain (without added myofascial pain) are the 
best candidates for this type of treatment. Regardless 
of whether HA or CO is injected, we at least can be 
sure that there will be no bone structural changes, as 
evidenced by Møystad et al. (13), in their study of 36 
patients with osteoarthritis in both TMJs.
Two studies (5,10) evaluated a total of 74 patients with 
TMJD assigned randomly and on a blind basis to ei-
ther HA (32 cases) or CO (29 cases). The results showed 
HA efficacy in securing remission of the symptoms of 
TMJD to be similar to that recorded in the CO group 
with no statistically significant differences between the 
two treatments in terms of oral opening and muscle or 
joint pain. Given the high quality of these studies, type 
A recommendation can be assumed, and the positive ef-
fects of both treatments over the short and long term are 
favorable to both the intraarticular application of HA 
and the use of CO in the treatment of TMJD.
The combination of HA with surgical procedures (ar-
throscopy or arthrocentesis) versus placebo with the 
same procedures has been examined by McCain et al. 
(11). The authors carried out a total of 55 arthroscopic 
procedures in the TMJ: 33 with HA injection and 22 
controls that received the injection of Ringer lactate so-
lution. The authors assessed the efficacy of the instru-
ments, visualization and arthroscopic imaging qual-
ity, the control of detritus, the control of intracapsular 
bleeding and tissue debridement. They found that the 
intraarticular application of HA during arthroscopy 
significantly improved these parameters in comparison 
with the controls. They likewise observed no short- or 
long-term complications of the use of HA.
The efficacy of arthrocentesis (AC) with and without 
the injection of HA was analyzed by Alpaslan et al. (2) 
in 41 joints of 31 patients with TMJD, 19 TMJs with 
RDD and 22 with joint block. The evaluation of the 
patients was made before the procedure, immediately 
afterwards, and postoperatively up until 24 months. 
The parameters recorded were maximum oral opening, 
laterality, pain intensity, mandibular function and the 
presence of sounds as assessed by a VAS. The authors 
observed increased oral opening, laterality and man-
dibular function that barely proved significant for the 
patients treated with AC and HA. Nevertheless, the pain 
and sounds decreased in both groups. The reduction in 
pain was greater in the AC and HA group. 
In another study, Alpaslan et al. (6) evaluated the nitrite, 
nitrate and thiobarbituric acid levels in 25 patients with 
TMJD: 10 treated with AC and 15 with AC and HA. The 
authors recorded significant improvement in mandibu-
lar function and a likewise significant reduction in ni-
trite, nitrate and thiobarbituric acid levels in the patients 
treated with AC and HA. 
From the analysis of the study published by McCain et 
al. (11), positive type A recommendation was deduced 
for the combined application of arthroscopy with HA, 
in view of the benefits afforded by viscosurgery during 
this surgical procedure in protecting the joint surfaces 
and facilitating the operation. However, as regards its 
effects upon the clinical symptoms, the authors found 
that the combination did not offer significant improve-
ments. On the other hand, the studies of Alpaslan et al. 
(2,6) yielded type A recommendation (2) and type B 
recommendation (6) favorable to the combination of 
arthrocentesis with HA-both studies showing this com-
bination to significantly improve the clinical signs and 
symptoms of patients with TMJD.
The Cochrane review suggests that HA can offer long-
term improvement of the signs and symptoms of TMJD, 
that its beneficial effects are on a par with those offered 
by glucocorticoids, and that some of the benefits can be 
obtained on combining with other techniques such as 
arthrocentesis or arthroscopy (8).
Based on the evidence found in the literature, we con-
sider that a multicenter, randomized, placebo-controlled 
double-blind study with a sufficiently large patient sam-
ple, well defined TMJD groups and the use of objective 
variables is absolutely necessary in order to establish 
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the true therapeutic effects of the intraarticular injec-
tion of HA in patients with TMJD, and to define the 
best posology.
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